FDA Approved: AGAMREE — Original Application (Catalyst Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved AGAMREE (vamorolone) from Catalyst Pharmaceuticals in an original NDA for Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• AGAMREE (Vamorolone)

Snippet

ORIG AP for AGAMREE (VAMOROLONE)